WAM
NMTC icon

Warberg Asset Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Warberg Asset Management’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,667
Closed -$27.1K – 207
2025
Q2 		$27.1K Buy
+6,667
New +$24.6K ﹤0.01% 146

Other funds holding NMTC

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Warberg Asset Management's NMTC Position: Q3 2025 in Review

Warberg Asset Management sold out of NeuroOne Medical Technologies (NMTC) in Q3 2025, closing a stake of 6,667 shares — an estimated $27.1K sold.

Warberg Asset Management first reported a position in NMTC in Q2 2025 and held it in 1 quarter. The position peaked at $27.1K in Q2 2025. 34 funds tracked by Wall St. Rank hold NMTC as of Q3 2025.

  • Warberg Asset Management reported no remaining NeuroOne Medical Technologies position as of Q3 2025 after selling out during the quarter.
  • Warberg Asset Management sold 6,667 NeuroOne Medical Technologies shares in Q3 2025, an estimated $27.1K.
  • Warberg Asset Management first reported a position in NeuroOne Medical Technologies in Q2 2025 and held it in 1 quarter.
  • Warberg Asset Management's NeuroOne Medical Technologies position peaked at $27.1K in Q2 2025.
  • 34 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q3 2025.

Based on Warberg Asset Management's 13F filing for Q3 2025, filed 6 Nov 2025.